SAN DIEGO, CA - March 20, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp., a pioneering biotechnology company specializing in computational enzyme engineering, is pleased to introduce our Chief Executive Officer (CEO) and Director, Mr. Naveen Kulkarni (“Mr. Kulkarni”). With a distinguished career in biotechnology, enzyme engineering, and sustainable manufacturing, Mr. Kulkarni has been committed to Quantumzyme’s mission of revolutionizing industrial biocatalysis with cutting-edge innovations.

A Proven Leader in Biocatalysis and Green Chemistry

With over two decades of experience in the biotech and pharmaceutical industries, Mr. Kulkarni has been instrumental in developing breakthrough enzymatic solutions for global industries. He has successfully led research initiatives and business strategies that have resulted in commercially viable, sustainable biocatalytic processes for pharmaceuticals, specialty chemicals, and biofuels. Mr. Kulkarni has an extensive background in enzyme engineering, computational biology, and green chemistry, making him a recognized thought leader in the space. His expertise in AI-driven enzyme design has contributed to the development of eco-friendly alternatives to traditional chemical synthesis, paving the way for cost-effective, high-yield manufacturing processes.

Driving Quantumzyme’s Future in Industrial Biotechnology

Under Mr. Kulkarni’s continued leadership, Quantumzyme aims to accelerate its expansion in global biocatalysis markets by:

• Advancing AI-powered enzyme engineering to create more efficient and stable industrial biocatalysts.
• Expanding sustainable solutions for pharmaceuticals, specialty chemicals, and renewable energy.
• Scaling up commercial applications of Quantumzyme’s proprietary enzyme optimization technology.
• Strengthening strategic partnerships with industry leaders to bring enzyme-driven solutions to market.
• Promoting reshoring of pharmaceutical manufacturing to the U.S. using green enzymatic processes.

A Vision for a Sustainable Future

“It is an honour to be the CEO of Quantumzyme, and as such I am committed to the advancement and growth of the Company in this exciting ever developing industry,” said Naveen Kulkarni. “Biocatalysis is redefining industrial chemistry, and Quantumzyme is at the forefront of this transformation. Our goal is to deliver scalable, cost-effective, and sustainable enzyme solutions that will revolutionize manufacturing processes across industries. I am both honoured and excited to lead Quantumzyme into this exciting new era.”

For the most current information and updates, please visit our website at www.quantumzymecorp.com. 

About Quantumzyme Corp.

Quantumzyme Corp. is a pioneering biotransformation company revolutionizing chemical processes through sustainable, enzyme-based solutions. Specializing in green chemistry, it harnesses quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to design high-performance biocatalysts that enhance efficiency, reduce waste, and minimize environmental impact. By integrating computational modeling with wet-lab validation, Quantumzyme delivers scalable, cost-effective biocatalysis solutions that improve industrial sustainability. Offering end-to-end enzyme development services—from discovery and engineering to process optimization and scale-up—Quantumzyme empowers its partners to adopt greener, more efficient production methods. Committed to sustainability and innovation, the company envisions a future where biotechnology drives global solutions for climate change, pollution, and resource efficiency, making eco-friendly biocatalysis the industry standard.

Disclaimer

The information contained in this press release is provided by Quantumzyme Corp. (“Quantumzyme”) for general informational purposes only. This release may include forward-looking statements that reflect Quantumzyme’s current expectations, estimates, projections, and assumptions about future events, business performance, market conditions, or technological developments. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. Forward-looking statements are based on management’s beliefs and assumptions as of the date of this press release and are subject to change without notice.

Quantumzyme makes no representations or warranties, express or implied, regarding the accuracy, completeness, or reliability of the information contained herein. The company undertakes no obligation to publicly update or revise any forward-looking statements as a result of new information, future developments, or changes in expectations, except as required by applicable law. Past performance should not be taken as an indicator of future results, and readers should not place undue reliance on any projections or expectations presented in this release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor does it provide financial, investment, or legal advice. Any references to market trends, scientific advancements, or industry insights are provided for contextual purposes only and should not be interpreted as endorsements, guarantees, or definitive predictions of future developments. Readers and investors are encouraged to conduct their own due diligence and seek independent professional advice before making any investment or business decisions related to Quantumzyme or its affiliates.

Media Contact:

Naveen Kulkarni
Chief Executive Officer
Quantumzyme Corp.
15656 Bernardo Center Drive, Suite 801
San Diego, CA 92127
Phone: +1 (858) 203-0312
Email: info@quantumzymecorp.com
Website: www.quantumzymecorp.com 

This press release is distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Quantumzyme Introduces Naveen Kulkarni as CEO To Lead the Next Phase of Innovation in Biocatalysis.